News >> Health >> Pharmaceutical Executive

Tuning Into CTV - Real Time Data For Marketers

How Clinical Trials Can Thrive in the Digital Era

Lasso's Endemic Marketplace Unlocks Elusive HCPs for BioPharm Communications

ProofPilot Announces Strategic Partnership with Savvy Cooperative

Biopharma Leaders Prepare to Navigate Medicare’s New Negotiating Power

Effects of Ransomware on the Pharmaceutical Industry

Top cybersecurity threats, challenges pharma companies need to address

How CROs Are Leveraging Innovation to Accelerate Clinical Trials

3 Reasons to Consider Tech Consolidation in your Life Sciences Learning Environment

Automating Study Setup with a Digital Data Flow

Clarivate Names Highly Cited Researcher 2022 Designations

Fingerpaint Group Introduces Fingerpaint Market Access

Optimizing Your Promotional Investment Mix: Harness the Power of AI

Brand Institute Partners on Brand Name Development for FDA-Approved Treatment for Pulmonary Arterial Hypertension

A Culture of Quality: The Catalyst to Accelerate Innovation

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

A Mission of the Heart

The New Reality for Industry Dealmaking May be Setting In

Is ESG a ‘Protection Racket’ or Long-Term Value Contributor?

Digital Biomarkers Could Reshape CNS Diagnosis, Treatment

Recaps, Live & In Person

Pharmaceutical Executive, November 2022 Issue (PDF)

In life sciences, the metaverse opportunity knocks

Indegene to Help Scale Cup AstraZeneca's Global Omnichannel Operations

How EU 536/2014 Will Revolutionize Global Clinical Trials

How to Have a Successful Promotional Content Journey from Pre-commercial to Post-launch

FDA Embroiled in Reproductive Rights Debate

Origins Insights Announces Transition to Patient Specialist Agency


2022-11-27 22:25:05